Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma.

Molecular medicine reports - 1 Mar 2016

Wu Tao, Leboeuf Céline, Durand Sarah, Su Bin, Deschamps Marina, Zhang Xiaowen, Ferrand Christophe, Pessaux Patrick, Robinet Eric

Abstract excerpt

Adoptive immunotherapy using autologous cytokine-induced killer (CIK) cells reduces the recurrence rate of hepatocellular carcinoma (HCC) in association with transarterial chemoembolization or radiofrequency. However, a large‑scale development of this immunotherapy remains difficult to consider in an autologous setting, considering the logistical hurdles associated with the production of this cell therapy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytotoxicity Tests, Immunologic

Share to HeLa Cells

Share to Immunotherapy, Adoptive

Share to Liver Neoplasms

Share to Transplantation, Homologous

Source

Identifiers

PMID: 26820174
DOI: 10.3892/mmr.2016.4811

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma.PMID 26820174Read ↗

Genetically modified and unmodified cellular approaches to enhance graft versus leukemia effect, without increasing graft versus host disease: the use of allogeneic cytokine-induced killer cellsSemantic proximity Read ↗

Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation.Semantic proximity Read ↗

The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study.Semantic proximity Read ↗

Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells.Semantic proximity Read ↗

Induction of allogeneic tumour- and lymphokine-activated lymphocytes against hepatocellular carcinoma.Semantic proximity Read ↗

Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood.Semantic proximity Read ↗

Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients.Semantic proximity Read ↗

Autologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomy.Semantic proximity Read ↗

Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastasesSemantic proximity Read ↗

The phenotype of ex vivo generated cytokine-induced killer cells is associated with overall survival in patients with cancer.Semantic proximity Read ↗

T-bet transduction enhances anti-tumor efficacy of IFN-producing dendritic cell (IKDC) against hepatocellular carcinoma via apoptosis induction.Semantic proximity Read ↗

Antitumor effects of natural killer cells derived from gene-engineered human induced pluripotent stem cells on hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.